MaxCyte Inc (GB:MXCT)
LSE:MXCT
Holding GB:MXCT?
Track your performance easily

MaxCyte (MXCT) Technical Analysis

9 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
MaxCyte Inc’s (MXCT) Moving Averages Convergence Divergence (MACD) indicator is -3.92, suggesting MaxCyte Inc is a Sell.
MaxCyte Inc’s (MXCT) 20-Day exponential moving average is 287.74, while MaxCyte Inc’s (MXCT) share price is 289p, making it a Buy.
MaxCyte Inc’s (MXCT) 50-Day exponential moving average is 298.05, while MaxCyte Inc’s (MXCT) share price is 289p, making it a Sell.

MaxCyte (MXCT) Pivot Points

Nov 08, 2024, 06:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
274.67
277.33
282.67
285.33
290.67
293.33
298.67
Fibonacci
277.33
280.39
282.28
285.33
288.39
290.28
293.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MaxCyte (MXCT) Moving Averages

Nov 08, 2024, 06:17 AM
Period
Simple
Exponential
MA5
282.80Buy
285.37Buy
MA10
284.70Buy
285.35Buy
MA20
287.55Buy
287.74Buy
MA50
297.74Sell
298.05Sell
MA100
316.15Sell
312.13Sell
MA200
334.46Sell
329.91Sell
MaxCyte Inc’s (MXCT) 10-Day exponential moving average is 285.35, while MaxCyte Inc’s (MXCT) share price is 289p, making it a Buy.
MaxCyte Inc’s (MXCT) 100-Day exponential moving average is 312.13, while MaxCyte Inc’s (MXCT) share price is 289p, making it a Sell.
MaxCyte Inc’s (MXCT) stock price is 289p and MaxCyte Inc’s (MXCT) 50-day simple moving average is 297.74, creating a Sell signal.
MaxCyte Inc’s (MXCT) stock price is 289p and MaxCyte Inc’s (MXCT) 100-day simple moving average is 316.15, creating a Sell signal.
MaxCyte Inc’s (MXCT) stock price is 289p and MaxCyte Inc’s (MXCT) 200-day simple moving average is 334.45, creating a Sell signal.

MaxCyte (MXCT) Technical Indicators

Nov 08, 2024, 06:17 AM
Name
Value
Implied Action
RSI (14)
48.82
Neutral
STOCH (9,6)
61.11
Neutral
STOCHRSI (14)
61.11
Neutral
MACD (12,26)
-3.92
Sell
ADX (14)
12.71
Buy
Williams %R
-29.17
Buy
CCI (14)
15.59
Neutral
ATR (14)
9.16
-
Ultimate Oscillator
65.53
Neutral
ROC
-1.03
Sell
MaxCyte Inc’s (MXCT) Relative Strength Index (RSI) is 48.82, creating a Neutral signal.
MaxCyte Inc’s (MXCT) Trend Strength Indicator (ADX) is 12.71, creating a Buy signal.
MaxCyte Inc’s (MXCT) Commodity Channel Index (CCI) is 15.59, creating a Neutral signal.
MaxCyte Inc’s (MXCT) Price Rate of Change (ROC) is -1.03, creating a Sell signal.

FAQ

Is MXCT a Buy, Hold, or Sell?
Based on MXCT’s technical indicators, MXCT is a Hold.
    What is MXCT’s RSI (14)?
    MXCT’s RSI (14) is 48.82, which suggests MXCT is a Neutral.
      What is MXCT’s MACD?
      MXCT’s MACD is -3.92, which suggests MXCT is a Sell.
        What is MXCT’s 5-day moving average?
        MXCT’s 5-day moving average is 282.80, which suggests MXCT is a Buy.
          What is MXCT’s 20-day moving average?
          MXCT 20-day moving average is 287.55, which suggests MXCT is a Buy.
            What is MXCT’s 50-day moving average?
            MXCT’s 50-day moving average is 297.74, which suggests MXCT is a Sell.
              What is MXCT’s 200-day moving average?
              MXCT’s 200-day moving average is 334.45, which suggests MXCT is a Sell.
                What is MXCT’s Williams % R (14)?
                MXCT’s Williams % R (14) is -29.17, which suggests MXCT is a Buy.
                  What is MXCT’s CCI (14)?
                  MXCT’s CCI (14) is 15.59, which suggests MXCT is a Neutral.
                    What is the share price of MaxCyte Inc?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis